MAPT and Blindness: Given the emerging evidence that tau-mediated neurodegeneration is caused by a combination of factors, including mitochondrial dysfunction (Thies and Mandelkow, 2007), it is plausible that MAPT variation contributes to the risk of blindness in LHON mtDNA mutation carriers.